PT72616B - Method for increasing oral absortion of beta-lactam antibiotics - Google Patents

Method for increasing oral absortion of beta-lactam antibiotics

Info

Publication number
PT72616B
PT72616B PT72616A PT7261681A PT72616B PT 72616 B PT72616 B PT 72616B PT 72616 A PT72616 A PT 72616A PT 7261681 A PT7261681 A PT 7261681A PT 72616 B PT72616 B PT 72616B
Authority
PT
Portugal
Prior art keywords
beta
lactam antibiotics
absortion
amide
ester
Prior art date
Application number
PT72616A
Other languages
English (en)
Other versions
PT72616A (en
Inventor
Toshiaki Nishihata
Takeru Higuchi
Original Assignee
Inter Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inter Research Corp filed Critical Inter Research Corp
Publication of PT72616A publication Critical patent/PT72616A/pt
Publication of PT72616B publication Critical patent/PT72616B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PT72616A 1980-03-07 1981-03-05 Method for increasing oral absortion of beta-lactam antibiotics PT72616B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12809980A 1980-03-07 1980-03-07

Publications (2)

Publication Number Publication Date
PT72616A PT72616A (en) 1981-04-01
PT72616B true PT72616B (en) 1985-10-04

Family

ID=22433628

Family Applications (1)

Application Number Title Priority Date Filing Date
PT72616A PT72616B (en) 1980-03-07 1981-03-05 Method for increasing oral absortion of beta-lactam antibiotics

Country Status (11)

Country Link
EP (1) EP0036534B1 (pt)
JP (1) JPS56128714A (pt)
AT (1) ATE29837T1 (pt)
DE (1) DE3176461D1 (pt)
DK (1) DK101981A (pt)
ES (1) ES500184A0 (pt)
FI (1) FI810637L (pt)
GR (1) GR74441B (pt)
IE (1) IE52973B1 (pt)
NO (1) NO159767C (pt)
PT (1) PT72616B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU541247B2 (en) * 1979-12-20 1985-01-03 R.P. Scherer Corporation Adjuvants for rectal delivery of drug substances
EP0177342A3 (en) * 1984-10-04 1987-12-02 Genentech, Inc. Oral formulation of therapeutic proteins
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
JPH05248655A (ja) * 1992-01-09 1993-09-24 Daikin Ind Ltd 空気調和装置
EP0570230B1 (en) * 1992-05-15 1998-09-30 Shiseido Company Limited External preparation for skin
US5424289A (en) * 1993-07-30 1995-06-13 Alza Corporation Solid formulations of therapeutic proteins for gastrointestinal delivery
FR2726468B1 (fr) 1994-11-03 1996-12-13 Oreal Utilisation de derive de l'acide salicylique comme stabilisant d'une emulsion huile-dans-eau
WO1998026803A1 (fr) * 1996-12-19 1998-06-25 Daiichi Pharmaceutical Co., Ltd. Composition pharmaceutique pour administration par voie orale

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1036194A (en) * 1962-03-26 1966-07-13 William Kurt Wallersteiner Improvements relating to antibiotic compositions
US3676434A (en) * 1970-07-29 1972-07-11 Lilly Co Eli Cephalosporin salts
US4210635A (en) * 1978-02-15 1980-07-01 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition

Also Published As

Publication number Publication date
JPS6346727B2 (pt) 1988-09-19
GR74441B (pt) 1984-06-28
FI810637L (fi) 1981-09-08
NO810758L (no) 1981-09-08
NO159767B (no) 1988-10-31
EP0036534A1 (en) 1981-09-30
EP0036534B1 (en) 1987-09-23
ES8301107A1 (es) 1982-12-01
ATE29837T1 (de) 1987-10-15
IE810452L (en) 1981-09-07
PT72616A (en) 1981-04-01
DK101981A (da) 1981-09-08
ES500184A0 (es) 1982-12-01
JPS56128714A (en) 1981-10-08
IE52973B1 (en) 1988-04-27
DE3176461D1 (en) 1987-10-29
NO159767C (no) 1989-02-08

Similar Documents

Publication Publication Date Title
AU6805781A (en) Oral absorption of polar bioactive agents
IL113894A (en) Oxalylamino-benzofuran- and benzothienyl- derivatives process for their preparation pharmaceutical compositions containing them and their use
HUT50779A (en) Process for producing alpha-substituted 4-/quinolin-2-yl-methoxy/-phenyl-acetic acids and esters and pharmaceutical compositions containing them
PT72616B (en) Method for increasing oral absortion of beta-lactam antibiotics
EP0041047A3 (de) Dioxidverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
ES8106528A1 (es) Un procedimiento para la preparacion de un compuesto de 1,1-dioxido de penam
PT72592A (en) Method of increasing oral absorption of glycosidic and related antibiotics
JPS55111463A (en) Beta-lactam compound and its preparation
ES8402819A1 (es) Procedimiento para la produccion de una 3,3-dialquil-o 3,3-dialquileno-indolina.
ES8604121A1 (es) Procedimiento para la preparacion de esteres de acido guani-dinobenzoico
PL245812A1 (en) Process for preparing 6-alpha-methoxy-6-beta(2-/methylphenoxycarbonyl/-2-/thienyl-3/-acetamido)-penicillanic acid
JPS5785389A (en) Novel antibiotic and its preparation

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19940405